KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX)

CUSIP: 492515101

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COMMON STOCK
Total 13F shares
51,206,772
Share change
+1,753,552
Total reported value
$663,619,021
Put/Call ratio
113%
Price per share
$12.95
Number of holders
123
Value change
+$22,709,876
Number of buys
3

Quarterly Holders Quick Answers

What is CUSIP 492515101?
CUSIP 492515101 identifies KERX - KERYX BIOPHARMACEUTICALS - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) as of Q4 2013

As of 31 Dec 2013, KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) was held by 123 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 51,206,772 shares. The largest 10 holders included Sectoral Asset Management Inc, State Street Corp, FMR LLC, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., FRANKLIN RESOURCES INC, BlackRock Fund Advisors, Cormorant Asset Management, LLC, WELLS FARGO & COMPANY/MN, and Allianz Asset Management AG. This page lists 123 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.